Daniel Friedman

674 total citations · 1 hit paper
20 papers, 455 citations indexed

About

Daniel Friedman is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Daniel Friedman has authored 20 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Daniel Friedman's work include Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Daniel Friedman is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Daniel Friedman collaborates with scholars based in United States, Canada and Australia. Daniel Friedman's co-authors include Ilan S. Schwartz, Tanis C. Dingle, Nelson Lee, Wendy Sligl, Lori Zapernick, Nathan Zelyas, Stephanie Smith, Karen Doucette, K. Halloran and Carlos Cervera and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and American Journal of Transplantation.

In The Last Decade

Daniel Friedman

17 papers receiving 438 citations

Hit Papers

Emerging Fungal Infections: New Patients, New Patterns, a... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Friedman United States 8 282 260 59 55 48 20 455
Edna Bash Israel 8 426 1.5× 352 1.4× 52 0.9× 38 0.7× 31 0.6× 10 520
Nilgün Çerikçioğlu Türkiye 13 370 1.3× 291 1.1× 53 0.9× 97 1.8× 31 0.6× 33 523
Rogelio de J. Treviño‐Rangel Mexico 13 393 1.4× 315 1.2× 85 1.4× 86 1.6× 42 0.9× 66 542
P.H. Chandrasekar United States 12 389 1.4× 306 1.2× 29 0.5× 71 1.3× 51 1.1× 23 563
Jelena Catania United States 6 620 2.2× 541 2.1× 54 0.9× 58 1.1× 49 1.0× 11 706
Neelam Sachdeva India 7 512 1.8× 419 1.6× 60 1.0× 45 0.8× 50 1.0× 13 599
M.A. Viviani Italy 9 440 1.6× 370 1.4× 46 0.8× 65 1.2× 43 0.9× 14 593
Samuel Bernal Spain 13 234 0.8× 269 1.0× 39 0.7× 59 1.1× 21 0.4× 25 427
Smita Sarma India 9 648 2.3× 577 2.2× 95 1.6× 57 1.0× 52 1.1× 22 790
Luis Thompson Chile 11 477 1.7× 406 1.6× 40 0.7× 36 0.7× 22 0.5× 29 595

Countries citing papers authored by Daniel Friedman

Since Specialization
Citations

This map shows the geographic impact of Daniel Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Friedman more than expected).

Fields of papers citing papers by Daniel Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Friedman. The network helps show where Daniel Friedman may publish in the future.

Co-authorship network of co-authors of Daniel Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Friedman. A scholar is included among the top collaborators of Daniel Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Friedman. Daniel Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Friedman, Daniel, Elitza S. Theel, Randall C. Walker, et al.. (2024). Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis. Open Forum Infectious Diseases. 11(4). ofae114–ofae114. 2 indexed citations
3.
Little, Jessica S, Eleftheria Kampouri, Daniel Friedman, et al.. (2024). The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention. Open Forum Infectious Diseases. 11(6). ofae133–ofae133. 26 indexed citations
5.
Bell, Elizabeth, Jennifer Pisano, & Daniel Friedman. (2024). Reply to Heldman et al. Open Forum Infectious Diseases. 11(6). ofae292–ofae292. 1 indexed citations
6.
Friedman, Daniel & Ilan S. Schwartz. (2023). Emerging Diagnostics and Therapeutics for Invasive Fungal Infections. Infectious Disease Clinics of North America. 37(3). 593–616. 10 indexed citations
7.
Friedman, Daniel, et al.. (2023). Current and Emerging Therapies for COVID-19 in Lung Transplantation. PubMed. 12(2). 23–35.
8.
Comba, Işın Y., Audrey N. Schuetz, Daniel Friedman, et al.. (2022). Antimicrobial Susceptibility of Elizabethkingia Species: Report from a Reference Laboratory. Journal of Clinical Microbiology. 60(6). 25 indexed citations
9.
Friedman, Daniel, et al.. (2022). Risk Factors and Outcomes of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study of United States Renal Data System Data. Clinical Infectious Diseases. 76(8). 1431–1439. 6 indexed citations
10.
Friedman, Daniel, Supavit Chesdachai, Fnu Shweta, & Maryam Mahmood. (2021). Enterococcus gallinarum endophthalmitis and meningitis in an allogeneic hematopoietic stem cell transplant patient: A case report and literature review. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 6(4). 313–318. 3 indexed citations
11.
Friedman, Daniel & Karen Doucette. (2021). Mycobacteria: Selection of Transplant Candidates and Post–lung Transplant Outcomes. Seminars in Respiratory and Critical Care Medicine. 42(3). 460–470. 7 indexed citations
12.
Chesdachai, Supavit, Daniel Friedman, Nicholas Boire, & Omar Abu Saleh. (2021). Disseminated blastomycosis in a kidney transplant recipient. Transplant Infectious Disease. 23(4). e13618–e13618. 2 indexed citations
13.
Schwartz, Ilan S., Daniel Friedman, Lori Zapernick, et al.. (2020). High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, Canada. Clinical Infectious Diseases. 71(7). 1760–1763. 75 indexed citations
14.
Friedman, Daniel, Carlos Cervera, K. Halloran, Gregory J. Tyrrell, & Karen Doucette. (2019). Non‐tuberculous mycobacteria in lung transplant recipients: Prevalence, risk factors, and impact on survival and chronic lung allograft dysfunction. Transplant Infectious Disease. 22(2). e13229–e13229. 20 indexed citations
15.
Friedman, Daniel & Ilan S. Schwartz. (2019). Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens. Journal of Fungi. 5(3). 67–67. 256 indexed citations breakdown →
16.
Friedman, Daniel, Sara Belga, Catherine Burton, Jutta K. Preiksaitis, & Dima Kabbani. (2019). 1754. Pre-Transplant Vaccination Rates in Solid-Organ Transplant Recipients. Open Forum Infectious Diseases. 6(Supplement_2). S643–S644. 1 indexed citations
17.
Cutajar, Dean, et al.. (2016). A comparison of entrance skin dose delivered by clinical angiographic c-arms using the real-time dosimeter: the MOSkin. Australasian Physical & Engineering Sciences in Medicine. 39(2). 423–430. 3 indexed citations
18.
Freeman, Anthony, et al.. (2011). Marked Reduction of Effective Radiation Dose in Patients Undergoing CT Coronary Angiography using Prospective ECG Gating. Heart Lung and Circulation. 20(8). 512–516. 8 indexed citations
19.
Friedman, Daniel, et al.. (2003). BOOK REVIEWS. Residential Treatment for Children & Youth. 21(1). 71–75.
20.
Feldman, Sandor, et al.. (1954). Mondor's disease.. PubMed. 54(3). 387–387. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026